AIM WINNERS & LOSERS: Futura Medical shares rise on US FDA agreement
AIM WINNERS & LOSERS: Futura Medical shares rise on US FDA agreement
Read moreWed, 13th May 2009 09:20
AIM WINNERS & LOSERS: Futura Medical shares rise on US FDA agreement
Read moreFutura Medical shares rise on FDA's agreement for MED3000 study
Read moreBROKER RATINGS: UBS raises Rightmove to buy, Computacenter to neutral
Read more(Sharecast News) - Futura Medical shares surged on Monday after the company said it had agreed with the US Food and Drug Administration on the protocol for a small confirmatory clinical study of its erectile dysfunction gel, MED3000.
Read more(Sharecast News) - Pharmaceuticals company Futura Medical said on Friday that the relevant EU notified body has completed the review of its technical dossier for 'MED3000', with a recommendation to certificate MED3000 as a class 2B approved medical device.
Read moreFutura Medical shares jump as erectile dysfunction drug nears approval
Read moreAIM WINNERS & LOSERS: Futura Medical up on EU medical device clearance
Read moreTRADING UPDATES: Futura signs development deal; UKOG gets day in court
Read moreAIM WINNERS & LOSERS: Futura Medical rises on financing transaction
Read moreIN BRIEF: Futura Medical Progresses MED3000 Regulatory Process
Read more(Sharecast News) - Pharmaceutical company Futura Medical updated the market on regulatory processes and commercial activities for MED3000 - its topical gel formulation for treatment of erectile dysfunction (ED).
Read moreUK TRADING UPDATE SUMMARY: Quartix Annual Earnings To Beat Consensus
Read moreIN BRIEF: Futura Medical Loss Narrows As MED3000 Approval Nears
Read more(Sharecast News) - Futura Medical reported a net loss of £1.06m in its first half on Wednesday, narrowing from a net loss of £4.46m year-on-year.
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read more